This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Syndax Pharmaceuticals, Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Galit Rosen: Innovator in Cancer Treatment
Introduction
Galit Rosen is a prominent inventor based in Newton, MA (US). She has made significant contributions to the field of cancer treatment through her innovative research and development of pharmaceutical compositions.
Latest Patents
Galit Rosen holds 1 patent for her invention titled "Combinations of menin inhibitors and CYP3A4 inhibitors and methods of use thereof." This patent focuses on the combination of menin inhibitors with one or more CYP3A4 inhibitors, which are crucial in treating cancer and other diseases mediated by the menin-HLL interaction. The invention provides compounds that inhibit menin and are useful in treating diseases mediated by the menin-MLL interaction when combined with a strong CYP3A4 inhibitor.
Career Highlights
Galit Rosen is currently associated with Syndax Pharmaceuticals, Inc., where she continues her groundbreaking work in the pharmaceutical industry. Her research has the potential to change the landscape of cancer treatment, offering new hope to patients.
Collaborations
Some of her notable coworkers include Gerard M Mcgeehan and Steven A Smith, who collaborate with her in advancing their shared goals in cancer research.
Conclusion
Galit Rosen's innovative work in developing new cancer treatments showcases her dedication to improving patient outcomes through scientific research. Her contributions are paving the way for future advancements in the field.